NCT04130061View on ClinicalTrials.gov

Human Amniotic Membrane to Decrease Post Operative Atrial Fibrillation

EARLY_PHASE1CompletedINTERVENTIONAL
Enrollment

27

Participants

Timeline

Start Date

October 11, 2019

Primary Completion Date

June 1, 2021

Study Completion Date

June 1, 2021

Conditions
Atrial Fibrillation
Interventions
BIOLOGICAL

Human Amniotic Membrane

Epicardial application of human amniotic membrane during cardiac surgery

Trial Locations (1)

84132

University of Utah, Salt Lake City

All Listed Sponsors
lead

University of Utah

OTHER

NCT04130061 - Human Amniotic Membrane to Decrease Post Operative Atrial Fibrillation | Biotech Hunter | Biotech Hunter